Microsoft Word - Scientific Program IGRT 2016 Madrid V3

Previous Page

Next Page

Page Background

The proof is in the pudding:

Margins too large ??

• No (few) marginal

recurrence

• Might limit dose

escalation and lead

to in-field

recurrence

Due et al R&O 2014